SCHEMBL20042724

SCHEMBL20042724

Cc1nc2c(c(N3CCC3)n1)CN(C(=O)C1CC1(C)C)C2

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
CHRNB3 Q05901 1/20 0.34
CHRNA6 Q15825 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
NR4A1 P22736 1/20 0.33
GPR55 Q9Y2T6 4/20 0.33
CNR1 P21554 3/20 0.33
KDM4E B2RXH2 1/20 0.32
GBA1 P04062 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
P2RX7 Q99572 1/20 0.31
MTOR P42345 1/20 0.30
CYP1A2 P05177 1/20 0.30
CHRM4 P08173 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042800 0.82 CNR1 (0.45) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042806 0.82 CNR1 (0.47) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042779 0.82 GPR55 (0.39) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042764 0.81 CNR1 (0.49) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042660 0.81 CNR1 (0.39) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042691 0.80 PIK3CD (0.38) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042785 0.80 CNR2 (0.36) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042793 0.80 SMN1; SMN2 (0.37) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042816 0.80 CNR1 (0.45) SMN1; SMN2LMNATSHRNR4A1GPR55
SCHEMBL20042870 0.79 KDM4E (0.35) SMN1; SMN2LMNATSHRNR4A1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed